These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26755150)

  • 1. Surface plasmon resonance immunosensor for ErbB2 breast cancer biomarker determination in human serum and raw cancer cell lysates.
    Eletxigerra U; Martinez-Perdiguero J; Barderas R; Pingarrón JM; Campuzano S; Merino S
    Anal Chim Acta; 2016 Jan; 905():156-62. PubMed ID: 26755150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amperometric magnetoimmunosensor for ErbB2 breast cancer biomarker determination in human serum, cell lysates and intact breast cancer cells.
    Eletxigerra U; Martinez-Perdiguero J; Merino S; Barderas R; Torrente-Rodríguez RM; Villalonga R; Pingarrón JM; Campuzano S
    Biosens Bioelectron; 2015 Aug; 70():34-41. PubMed ID: 25791465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of soluble ERBB2 in breast cancer cell lysates using a combined label-free/fluorescence platform based on Bloch surface waves.
    Sinibaldi A; Sampaoli C; Danz N; Munzert P; Sibilio L; Sonntag F; Occhicone A; Falvo E; Tremante E; Giacomini P; Michelotti F
    Biosens Bioelectron; 2017 Jun; 92():125-130. PubMed ID: 28209555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive and selective analysis of a wide concentration range of IGFBP7 using a surface plasmon resonance biosensor.
    Jang DH; Choi Y; Choi YS; Kim SM; Kwak H; Shin SH; Hong S
    Colloids Surf B Biointerfaces; 2014 Nov; 123():887-91. PubMed ID: 25466460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-low fouling alkylimidazolium modified surfaces for the detection of HER2 in breast cancer cell lysates [corrected].
    Aubé A; Campbell S; Schmitzer AR; Claing A; Masson JF
    Analyst; 2017 Jun; 142(13):2343-2353. PubMed ID: 28560368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface plasmon resonance immunoassay for the detection of the TNFα biomarker in human serum.
    Martinez-Perdiguero J; Retolaza A; Bujanda L; Merino S
    Talanta; 2014 Feb; 119():492-7. PubMed ID: 24401446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid and sensitive phenotypic marker detection on breast cancer cells using surface-enhanced Raman scattering (SERS) imaging.
    Lee S; Chon H; Lee J; Ko J; Chung BH; Lim DW; Choo J
    Biosens Bioelectron; 2014 Jan; 51():238-43. PubMed ID: 23973735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple aptamer-functionalized gold nanorods based biosensor for the sensitive detection of MCF-7 breast cancer cells.
    Li Y; Zhang Y; Zhao M; Zhou Q; Wang L; Wang H; Wang X; Zhan L
    Chem Commun (Camb); 2016 Mar; 52(20):3959-61. PubMed ID: 26882343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
    Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multicolor Immunosensor for Sensitive Visual Detection of Breast Cancer Biomarker Based on Sensitive NADH-Ascorbic-Acid-Mediated Growth of Gold Nanobipyramids.
    Wang Z; Chen Q; Zhong Y; Yu X; Wu Y; Fu F
    Anal Chem; 2020 Jan; 92(1):1534-1540. PubMed ID: 31790576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface plasmon resonance based immunosensor for the detection of the cancer biomarker carcinoembryonic antigen.
    Altintas Z; Uludag Y; Gurbuz Y; Tothill IE
    Talanta; 2011 Oct; 86():377-83. PubMed ID: 22063554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrochemical aptamer/antibody based sandwich immunosensor for the detection of EGFR, a cancer biomarker, using gold nanoparticles as a signaling probe.
    Ilkhani H; Sarparast M; Noori A; Zahra Bathaie S; Mousavi MF
    Biosens Bioelectron; 2015 Dec; 74():491-7. PubMed ID: 26176209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cetuximab enhances the anti-proliferative effect of trastuzumab in ERBB2 over-expressing breast cancer cells--preliminary study.
    Uberall I; Krízová K; Steigerová J
    Klin Onkol; 2011; 24(5):356-60. PubMed ID: 22070017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrochemical immunosensor for the analysis of the breast cancer biomarker HER2 ECD.
    Marques RC; Viswanathan S; Nouws HP; Delerue-Matos C; González-García MB
    Talanta; 2014 Nov; 129():594-9. PubMed ID: 25127638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bloch Surface Waves Biosensors for High Sensitivity Detection of Soluble ERBB2 in a Complex Biological Environment.
    Sinibaldi A; Sampaoli C; Danz N; Munzert P; Sonntag F; Centola F; Occhicone A; Tremante E; Giacomini P; Michelotti F
    Biosensors (Basel); 2017 Aug; 7(3):. PubMed ID: 28817097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A label-free electrochemical affisensor for cancer marker detection: The case of HER2.
    Ravalli A; da Rocha CG; Yamanaka H; Marrazza G
    Bioelectrochemistry; 2015 Dec; 106(Pt B):268-75. PubMed ID: 26260578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A biosensor capable of identifying low quantities of breast cancer cells by electrical impedance spectroscopy.
    Huerta-Nuñez LFE; Gutierrez-Iglesias G; Martinez-Cuazitl A; Mata-Miranda MM; Alvarez-Jiménez VD; Sánchez-Monroy V; Golberg A; González-Díaz CA
    Sci Rep; 2019 Apr; 9(1):6419. PubMed ID: 31015522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface Plasmon Resonance Immunosensor with Antibody-Functionalized Magnetoplasmonic Nanoparticles for Ultrasensitive Quantification of the CD5 Biomarker.
    Kausaite-Minkstimiene A; Popov A; Ramanaviciene A
    ACS Appl Mater Interfaces; 2022 May; 14(18):20720-20728. PubMed ID: 35499973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ErbB2 and the antimetastatic nm23/NDP kinase in regulating serum induced breast cancer invasion.
    Tommasi S; Fedele V; Crapolicchio A; Bellizzi A; Paradiso A; Reshkin SJ
    Int J Mol Med; 2003 Jul; 12(1):131-4. PubMed ID: 12792823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An SPR based immunoassay for the sensitive detection of the soluble epithelial marker E-cadherin.
    Vergara D; Bianco M; Pagano R; Priore P; Lunetti P; Guerra F; Bettini S; Carallo S; Zizzari A; Pitotti E; Giotta L; Capobianco L; Bucci C; Valli L; Maffia M; Arima V; Gaballo A
    Nanomedicine; 2018 Oct; 14(7):1963-1971. PubMed ID: 29902526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.